PPP1R13L and heart disorder: The pathophysiologic heterogeneity based on the genetic background of patients with heart diseases has also important therapeutic implications, for example, patients with impaired iASPP function may be predisposed to dilative remodeling after myocarditis or myocardial infraction and therefore benefit from personalized tailored anti‐inflammatory intervention.